Israel to expand use of COVID drug that gets 88% of patients out of hospital
Wednesday, August 11, 2021 | Tag Cloud Tags: covid-19, Israel, Jerusalem, News, Worthy News | Learn about out FREE SYNDICATION
(Worthy News) – The Health Ministry has approved the expanded use of an innovative COVID-19 treatment that helped 15 out of 17 severe patients who took it to be released from the hospital one day after receiving their final dose.
The drug, MesenCure, has been tested by Rambam Medical Center as part of a Phase I/II trial. The ministry has approved allowing any interested Israeli hospital to take part in the Phase II trial and to use the drug for additional approved patients.
The goal of the expanded trial, which will include a minimum of 50 patients, is to confirm the safety and efficacy of the drug, which was developed by Bonus BioGroup. [ Source: Jerusalem Post (Read More…) ]
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.